Okay, let me try to work through this. The question is about the effect of inhibiting the myenteric plexus. First, I need to recall what the myenteric plexus does. It's part of the enteric nervous system, right? The enteric nervous system controls gastrointestinal motility. The myenteric plexus is located between the longitudinal and circular muscle layers of the gut wall. Its main role is to regulate peristalsis and segmentation movements.

So, if the myenteric plexus is inhibited, what happens? If it's responsible for coordinating muscle contractions in the gut, inhibiting it would probably reduce or stop those movements. That could lead to decreased motility. Let me think about the options. If the correct answer is something like "paralytic ileus" or "constipation," that makes sense because the gut can't move properly without the plexus functioning.

Now, the incorrect options might include things like increased secretion, which would be more related to the submucosal plexus (Meissner's plexus), which controls secretion and blood flow. So if an option mentions secretion, that's probably wrong. Another option might be about increased peristalsis, which is the opposite of what inhibition would do. Also, maybe something like "gastric acid hypersecretion" if that's an option, but again, that's not related to the myenteric plexus.

The core concept here is the function of the enteric nervous system's two main plexuses: myenteric (Auerbach's) for motility and submucosal (Meissner's) for secretion and blood flow. Inhibiting the myenteric would affect motility. So the correct answer would relate to impaired gut motility, like paralytic ileus.

For the clinical pearl, remembering that Auerbach's plexus is motility, Meissner's is secretion. So if a drug inhibits Auerbach's, you get constipation or ileus. Also, in conditions like Hirschsprung's disease, there's absence of ganglion cells in the myenteric plexus, leading to functional obstruction. So that's a high-yield fact.

**Core Concept**
The myenteric (Auerbach’s) plexus regulates gastrointestinal motility by coordinating peristalsis and segmentation. Its inhibition disrupts neuromuscular signaling, leading to impaired propulsion of intestinal contents.

**Why the Correct Answer is Right**
Inhibiting the myenteric plexus blocks parasympathetic and intrinsic neural signals that drive smooth muscle contractions in the gut wall. This causes **paralytic ileus**, a condition characterized by functional obstruction due to loss of peristalsis. The plexus contains ganglion cells and interneurons that integrate motor and sensory inputs, and its disruption halts coordinated peristaltic waves.

**Why Each Wrong Option is Incorrect**
**Option A:** *Increased intestinal secretion* — Secretion is controlled by the submucosal (Meissner’s) plexus, not the myenteric plexus.
**Option B:** *Enhanced gastric acid secretion* — Gastric acid is regulated by parietal cells, not the myenteric plexus.

✓ Correct Answer: C. Decreased gut motility